ACROBiosystems
Dr. Tianfu Zhang graduated from Nanjing University with his PhD in biology. After working in over 10 years in CGT-related research, production, and quality management, he has an extensive background in a wide variety of cell therapies, including DC, CAR-T, TCR-T, iPSC, and gene therapies. He has published over 7 SCI-level papers with over 20+ patents. Dr. Zhang is currently responsible for the R&D of CGT Reagents for Cell Therapy Manufacturing, focusing on process and quality control challenges.
SCALABLE FEEDER-FREE IN VITRO DIFFERENTIATION OF STEM CELL-DERIVED NK CELLS
Wednesday, June 11, 2025
12:30 PM – 1:30 PM HK Time